The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival
Abstract
INTRODUCTION: osteoporosis is a common disease, and the incidence of osteoporotic fractures is expected to rise with the growing elderly population. Immediately following, and probably several years after a hip fracture, patients, both men and women, have a higher risk of dying compared to the general population regardless of age. The aim of this study was to assess excess mortality following hip fracture and, if possible, identify reasons for the difference between mortality for the two genders. METHODS: this is a nationwide register-based cohort study presenting data from the National Hospital Discharge Register on mortality, comorbidity and medication for all Danish patients (more than 41,000 persons) experiencing a hip fracture between 1 January 1999 and 31 December 2002. Follow-up period was until 31 December 2005. RESULTS: we found a substantially higher mortality among male hip fracture patients than female hip fracture patients despite men being 4 years younger at the time of fracture. Both male and female hip fracture patients were found to have an excess mortality rate compared to the general population. The cumulative mortality at 12 months among hip fracture patients compared to the general population was 37.1% (9.9%) in men and 26.4% (9.3%) in women. In the first year, the risk of death significantly increased for women with increasing age (hazard ratio, HR: 1.06, 95% confidence interval, CI: 1.06-1.07), the number of comedications (HR 1.04, 95% CI 1.03-1.05) and the presence of specific Charlson index components and medications described below. For men, age (HR 1.07, 95% CI 1.07-1.08), number of comedications (HR 1.06, 95% CI 1.04-1.07) and presence of different specific Charlson index components and medications increased the risk. Long-term survival analyses revealed that excess mortality for men compared with women remained strongly significant (HR 1.70, 95% CI 1.65-1.75, P < 0.001), even when controlled for age, fracture site, the number of medications, exposure to drug classes A, C, D, G, J, M, N, P, S and for chronic comorbidities. CONCLUSION: excess mortality among male patients cannot be explained by controlling for known comorbidity and medications. Besides gender, we found higher age and multimorbidity to be related to an increased risk of dying within the first year after fracture; acute complications might be one of the explanations. This study emphasises the need for particular rigorous postoperative diagnostic evaluation and treatment of comorbid conditions in the male hip fracture patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Risk Factors for Falls among Elderly Persons Living in the Community
Tinetti, M. E., Speechley, M., & Ginter, S. F. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192604 · Cited by 6,509
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003
Roche, J. J. W., Wenn, R. T., Sahota, O., & Moran, C. G. (2005) · BMJ · doi:10.1136/bmj.38643.663843.55 · Cited by 1,430
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Men: good health and high mortality. Sex differences in health and aging
Oksuzyan, A., Juel, K., Vaupel, J. W., & Christensen, K. (2008) · Aging Clinical and Experimental Research · doi:10.1007/bf03324754 · Cited by 692
Undertreatment of Osteoporosis in Men With Hip Fracture
Kiebzak, G. M., Beinart, G. A., Perser, K., Ambrose, C. G., Siff, S. J., & Heggeness, M. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2217 · Cited by 384
Differences in mortality after fracture of hip: the East Anglian audit
Todd, C. J., Freeman, C. J., Camilleri-Ferrante, C., Palmer, C. R., Hyder, A., Laxton, C. E., Parker, M. J., Payne, B. V., & Rushton, N. (1995) · BMJ · doi:10.1136/bmj.310.6984.904 · Cited by 323
Hip Fractures in the Elderly: Predictors of One Year Mortality
Aharonoff, G. B., Koval, K. J., Skovron, M. L., & Zuckerman, J. D. (1997) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-199704000-00004 · Cited by 314
Gender Differences in Patients With Hip Fracture: A Greater Risk of Morbidity and Mortality in Men
Endo, Y., Aharonoff, G. B., Zuckerman, J. D., Egol, K. A., & Koval, K. J. (2005) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-200501000-00006 · Cited by 265
Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1680-8 · Cited by 227
Use of antiepileptic drugs and risk of fractures: Case–control study among patients with epilepsy
Souverein, P. C., Webb, D. J., Weil, J. G., Van Staa, T. P., & Egberts, A. C. G. (2006) · Neurology · doi:10.1212/01.wnl.0000210503.89488.88 · Cited by 214
Psychotropic Medications and the Risk of Fracture: A Meta-Analysis
Takkouche, B., Montes-Mart??nez, A., Gill, S. S., & Etminan, M. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00006 · Cited by 204
A Comprehensive Hip Fracture Program Reduces Complication Rates and Mortality
Pedersen, S. J., Borgbjerg, F. M., Schousboe, B., Pedersen, B. D., Jørgensen, H. L., Duus, B. R., Lauritzen, J. B., & Hip Fracture Group of Bispebjerg Hospital (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01945.x · Cited by 180
Hip fracture patients are not treated for osteoporosis: A call to action
Harrington, J. T., Broy, S. B., Derosa, A. M., Licata, A. A., & Shewmon, D. A. (2002) · Arthritis Care & Research · doi:10.1002/art.10787 · Cited by 154
López, J. A., Cordero-Guevara, J. A., Alonso-Valdivielso, J. L., & Fernández-Melón, J. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1740-0 · Cited by 154
Tobacco smoking and risk of hip fracture in men and women
Høidrup, S., Prescott, E., Sørensen, T. I., Gottschau, A., Lauritzen, J. B., Schroll, M., & Grønbæk, M. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.253 · Cited by 142
Quality of life, morbidity, and mortality after low trauma hip fracture in men
Pande, I., Scott, D. L., O’Neill, T. W., Pritchard, C., Woolf, A. D., & Davis, M. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034611 · Cited by 139
Bergström, U., Björnstig, U., Stenlund, H. C., Jonsson, H., & Svensson, O. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0549-z · Cited by 131
Incidence of hip fracture in New South Wales: are our efforts having an effect?
Boufous, S., Finch, C. F., & Lord, S. R. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06124.x · Cited by 107
Has Mortality After a Hip Fracture Increased?
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01420.x · Cited by 103
Siris, E. S., Bilezikian, J. P., Rubin, M. R., Black, D. M., Bockman, R. S., Bone, H. G., Hochberg, M. C., McClung, M. R., & Schnitzer, T. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030568 · Cited by 92
Piirtola, M., Vahlberg, T. J., Löppönen, M. K., et al. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-008-9289-4 · Cited by 85
Roerholt, C., Eiken, P., & Abrahamsen, B. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0651-x · Cited by 85
Self-citationOlsen, T. S., Dehlendorff, C., & Andersen, K. K. (2007) · Neuroepidemiology · doi:10.1159/000112464 · Cited by 83
Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture
Murray, A., McQuillan, C., Kennon, B., & Gallacher, S. (2005) · Injury · doi:10.1016/j.injury.2005.03.012 · Cited by 58
Secondary Prevention of Hip Fractures Among the Hospitalized Elderly
Kamel, H. K. (2005) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000158545.26370.5c · Cited by 35
Determing Factors of Mortality in the Elderly with Hip Fractures.
Koike, Y., Imaizumi, H., Takahashi, E., Matsubara, Y., & Komatsu, H. (1999) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.188.139 · Cited by 17
Cited by
Gender Disparities in Osteoporosis
Alswat, K. A. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2970w · Cited by 596
Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project
Katsoulis, M., Benetou, V., Karapetyan, T., Feskanich, D., Grodstein, F., Pettersson‐Kymmer, U., Eriksson, S., Wilsgaard, T., Jørgensen, L., Ahmed, L. A., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12586 · Cited by 358
Lewiecki, E. M., Blicharski, T., Goemaere, S., Lippuner, K., Meisner, P. D., Miller, P. D., Miyauchi, A., Maddox, J., Chen, L., & Horlait, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02163 · Cited by 328
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Functional Recovery After Hip Fracture
Auais, M., Sheehan, K., Magaziner, J., & Beaupre, L. (2022) · Senior Trauma Patients · doi:10.1007/978-3-030-91483-7_37 · Cited by 309
Metadata
- Authors
- Kannegaard, P. N., van der Mark, S., Eiken, P., & Abrahamsen, B.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-14
- Volume
- 39
- Issue
- 2
- Pages
- 203-209
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2158748006
- Cited by
- 538
- References
- 28
- FWCI
- 27.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.